EDCTP Alumni Network

Fostering excellence and collaboration in the next generation of researchers

All Profiles

Professor Alexander Yaw Debrah

Call Senior Fellowship (SF)
Programme EDCTP2
Start Date 2020-01-01
End Date 2024-12-31
Project Code TMA2018SF-2451
Status Active

Title

Alternative treatment strategies using anti-wolbachial drugs to accelerate elimination of onchocerciasis and lymphatic filariasis

Host Organisation

Institution Country
Kwame Nkrumah University of Science and Technology (KNUST) Ghana

Current Organisation

Kwame Nkrumah University of Science and Technology

Current Job Title

Lecturer/Research scientist

Students Supervised

Type Name Title University Start Date End Date
Masters Prince Obeng Mr Kwame Nkrumah University of Science and Technology 2021 2022
Masters John Boateng Mr Kwame Nkrumah University of Science and Technology 2021 2022
PhD Monica Ahiadome Ms Kwame Nkrumah University of Science and Technology 2021 2024
PhD Emmanuel Kutu Mr Kwame Nkrumah University of Science and Technology 2022 2025

Memberships

Role Committee/board Start Date End Date

Education

Institution Degree Year
Kwame Nkrumah University of Science and Technology, Ghana Bachelor of Science
Kwame Nkrumah University of Science and Technology, Ghana Master of Philosophy
Bonn University/Kwame Nkrumah University of Science and Technology, Germany PhD

Areas Of Specialisation

Neglected Infectious Diseases (NID)

Grants

Tackling the Obstacles of Filariasis and Podoconiosis Disease Control
Grant Code:
VN 81204851
Source of funding:
German Ministry of Education and Research
Amount:
2777880.00
Role:
Principal Investigator
Start Date:
2017-01-01
End Date:
2022-01-01

Publications

Projects

The efficacy of Rifapentine 900mg/d plus Moxifloxacin 400mg/d given for 14 or 7 days against Onchoce
Fellow:
Alexander Yaw Debrah
Collaborators:
Name Country Institution
Alex Debrah Ghana Kwame Nkrumah University of Science and Technology
Achim Hoerauf Germany • University Hospital Bonn
Objectives:
This study intends to show efficacy (Wolbachia depletion) of the combination treatment of Rifapentine and Moxifloxacin against onchocerciasis
Sites:
Kumasi
Study Design:
Clinical Trial
Subjects:
onchocerciasis patients
Outcomes:
Ongoing
Start Date:
2019-07-01
End Date:
2023-02-07

Send a Message